GB9921387D0 - Antitumour activity strengthening method of crude drugs,composition containing crude drug strengthening antitumour activity,evaluating method of antitumour - Google Patents
Antitumour activity strengthening method of crude drugs,composition containing crude drug strengthening antitumour activity,evaluating method of antitumourInfo
- Publication number
- GB9921387D0 GB9921387D0 GBGB9921387.8A GB9921387A GB9921387D0 GB 9921387 D0 GB9921387 D0 GB 9921387D0 GB 9921387 A GB9921387 A GB 9921387A GB 9921387 D0 GB9921387 D0 GB 9921387D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antitumour
- strengthening
- antitumour activity
- activity
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/071—Agaricus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26375398 | 1998-09-17 | ||
| JP10323374A JP2000159682A (en) | 1998-09-17 | 1998-11-13 | Crude drug antitumor activity enhancing method, antitumor activity enhancing crude drug-containing composition, antitumor efficacy evaluating method of crude drug treatment, and antitumor efficacy evaluating method of crude drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9921387D0 true GB9921387D0 (en) | 1999-11-10 |
| GB2341800A GB2341800A (en) | 2000-03-29 |
Family
ID=26546176
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9920710.2A Ceased GB9920710D0 (en) | 1998-09-17 | 1999-09-03 | Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity, |
| GB9921387A Withdrawn GB2341800A (en) | 1998-09-17 | 1999-09-13 | Activating antitumour polysaccharide drugs |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9920710.2A Ceased GB9920710D0 (en) | 1998-09-17 | 1999-09-03 | Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity, |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JP2000159682A (en) |
| KR (1) | KR20000023206A (en) |
| CN (1) | CN1255376A (en) |
| AU (1) | AU4486299A (en) |
| BE (1) | BE1012725A5 (en) |
| CA (1) | CA2282234A1 (en) |
| DE (1) | DE19944695A1 (en) |
| DK (1) | DK199901235A (en) |
| ES (1) | ES2155802B1 (en) |
| FR (2) | FR2783426A1 (en) |
| GB (2) | GB9920710D0 (en) |
| ID (1) | ID23150A (en) |
| IL (1) | IL131722A0 (en) |
| IS (1) | IS5183A (en) |
| IT (1) | IT1307267B1 (en) |
| NL (2) | NL1013049C2 (en) |
| NO (1) | NO994463L (en) |
| SE (2) | SE9903307L (en) |
| SG (1) | SG76631A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040039195A (en) * | 2001-04-27 | 2004-05-10 | 아지노모토 가부시키가이샤 | Immunopotentiators |
| CA2445713A1 (en) * | 2001-05-07 | 2002-11-14 | Gab-Gyun Shin | A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| JP4499979B2 (en) * | 2001-05-21 | 2010-07-14 | コンビ株式会社 | Composition for controlling pathogen infection |
| WO2002098440A1 (en) * | 2001-06-01 | 2002-12-12 | Ajinomoto Co., Inc. | Drugs for diabetes |
| US7977379B2 (en) | 2002-05-15 | 2011-07-12 | Bhn Co., Ltd. | Method for angiogenesis inhibition or immunostimulation |
| JP4826696B2 (en) * | 2003-04-07 | 2011-11-30 | ビーエイチエヌ株式会社 | Angiogenesis inhibitors |
| JP4681801B2 (en) * | 2002-05-15 | 2011-05-11 | ビーエイチエヌ株式会社 | Angiogenesis inhibitor and method for producing the same |
| JP2005089417A (en) * | 2003-09-19 | 2005-04-07 | Noevir Co Ltd | Composition for prevention/treatment of diabetes |
| JP4587441B2 (en) * | 2004-02-12 | 2010-11-24 | 株式会社クレハ | Novel diabetes treatment and food |
| US8034386B2 (en) | 2004-09-17 | 2011-10-11 | Ssi Co., Ltd. | Extract from Agaricus blazei Murill capable of suppressing breast cancer |
| JP2006273835A (en) * | 2005-03-04 | 2006-10-12 | Michishi Tani | Malignant tumor therapeutic agent and food and drink containing the same |
| US20120128856A1 (en) * | 2009-07-31 | 2012-05-24 | Ming East-West, Llc | Maitake mushroom coffee |
| JPWO2011081024A1 (en) * | 2009-12-29 | 2013-05-09 | 株式会社富士見養蜂園 | Umami food and production method thereof |
| CN106309511A (en) * | 2016-08-30 | 2017-01-11 | 青海民族大学 | Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part |
| CN106333969A (en) * | 2016-08-30 | 2017-01-18 | 青海民族大学 | Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application |
| WO2019104579A1 (en) * | 2017-11-30 | 2019-06-06 | SHIEH, Darbin | Method for predicting and modulating susceptibility of cancer cell to programmed cell death |
| KR102602787B1 (en) * | 2020-12-16 | 2023-11-17 | 대한민국 | Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa |
| KR102646421B1 (en) * | 2020-12-16 | 2024-03-12 | 대한민국 | Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa |
| KR102584680B1 (en) * | 2020-12-17 | 2023-10-06 | 대한민국 | Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5276413A (en) * | 1975-12-18 | 1977-06-27 | Kureha Chem Ind Co Ltd | Production of oncostatic substances |
| US4177108A (en) * | 1977-03-02 | 1979-12-04 | Tetsuro Ikekawa | Process for producing emitanin |
| DE2842691A1 (en) * | 1978-09-30 | 1980-04-10 | Karl Dr Med Theurer | Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field |
| JPS57206618A (en) * | 1981-06-12 | 1982-12-18 | Noda Shiyokukin Kogyo Kk | Preparation of antitumor substance |
| JPH02203765A (en) * | 1989-02-02 | 1990-08-13 | Nippon Beet Sugar Mfg Co Ltd | Food having antitumor function and production thereof |
| JP3357383B2 (en) * | 1991-08-14 | 2002-12-16 | 昌宏 黒田 | Low molecular weight plant composition |
| JP2955126B2 (en) * | 1992-06-22 | 1999-10-04 | 笑代 丹羽 | Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof |
| US6015913A (en) * | 1996-09-06 | 2000-01-18 | Mars, Incorporated | Method for producing fat and/or solids from cocoa beans |
-
1998
- 1998-11-13 JP JP10323374A patent/JP2000159682A/en active Pending
-
1999
- 1999-08-31 AU AU44862/99A patent/AU4486299A/en not_active Abandoned
- 1999-08-31 SG SG1999004406A patent/SG76631A1/en unknown
- 1999-09-02 IL IL13172299A patent/IL131722A0/en unknown
- 1999-09-03 DK DK199901235A patent/DK199901235A/en not_active Application Discontinuation
- 1999-09-03 GB GBGB9920710.2A patent/GB9920710D0/en not_active Ceased
- 1999-09-13 GB GB9921387A patent/GB2341800A/en not_active Withdrawn
- 1999-09-14 IT IT1999TO000784A patent/IT1307267B1/en active
- 1999-09-15 NO NO994463A patent/NO994463L/en not_active Application Discontinuation
- 1999-09-15 NL NL1013049A patent/NL1013049C2/en not_active IP Right Cessation
- 1999-09-16 ES ES009902062A patent/ES2155802B1/en not_active Expired - Lifetime
- 1999-09-16 KR KR1019990039799A patent/KR20000023206A/en not_active Withdrawn
- 1999-09-16 CA CA002282234A patent/CA2282234A1/en not_active Abandoned
- 1999-09-16 SE SE9903307A patent/SE9903307L/en not_active Application Discontinuation
- 1999-09-16 FR FR9911586A patent/FR2783426A1/en not_active Withdrawn
- 1999-09-17 ID IDP990871D patent/ID23150A/en unknown
- 1999-09-17 CN CN99122136A patent/CN1255376A/en active Pending
- 1999-09-17 DE DE19944695A patent/DE19944695A1/en not_active Withdrawn
- 1999-09-17 BE BE9900625A patent/BE1012725A5/en not_active IP Right Cessation
- 1999-09-17 IS IS5183A patent/IS5183A/en unknown
-
2000
- 2000-03-01 FR FR0002640A patent/FR2788697A1/en not_active Withdrawn
-
2001
- 2001-01-24 SE SE0100195A patent/SE0100195D0/en not_active Application Discontinuation
-
2002
- 2002-01-07 NL NL1019705A patent/NL1019705C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1255376A (en) | 2000-06-07 |
| CA2282234A1 (en) | 2000-03-17 |
| NL1019705C2 (en) | 2002-03-26 |
| ITTO990784A1 (en) | 2001-03-14 |
| NL1019705A1 (en) | 2002-01-29 |
| SE9903307L (en) | 2000-03-18 |
| DK199901235A (en) | 2000-03-18 |
| SE0100195L (en) | 2001-01-24 |
| ITTO990784A0 (en) | 1999-09-14 |
| NL1013049A1 (en) | 2000-03-21 |
| DE19944695A1 (en) | 2000-03-30 |
| SE9903307D0 (en) | 1999-09-16 |
| ID23150A (en) | 2000-03-23 |
| ES2155802A1 (en) | 2001-05-16 |
| NO994463L (en) | 2000-03-20 |
| NL1013049C2 (en) | 2002-01-11 |
| IL131722A0 (en) | 2001-03-19 |
| JP2000159682A (en) | 2000-06-13 |
| KR20000023206A (en) | 2000-04-25 |
| BE1012725A5 (en) | 2001-02-06 |
| SG76631A1 (en) | 2000-11-21 |
| IT1307267B1 (en) | 2001-10-30 |
| GB2341800A (en) | 2000-03-29 |
| GB9920710D0 (en) | 1999-11-03 |
| FR2783426A1 (en) | 2000-03-24 |
| NO994463D0 (en) | 1999-09-15 |
| AU4486299A (en) | 2000-03-30 |
| IS5183A (en) | 2000-03-17 |
| FR2788697A1 (en) | 2000-07-28 |
| ES2155802B1 (en) | 2001-12-01 |
| SE0100195D0 (en) | 2001-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9921387D0 (en) | Antitumour activity strengthening method of crude drugs,composition containing crude drug strengthening antitumour activity,evaluating method of antitumour | |
| HUP0103542A3 (en) | 4,4-biarylpiperidine derivatives with opioid receptor activity and pharmaceutical compositions containing them | |
| HUP0102313A3 (en) | Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates | |
| HUP0600592A2 (en) | Substituted imidazopyridines, pharmaceutical compositions containing them and intermediates | |
| HUP0004225A3 (en) | Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
| HUP0401923A3 (en) | New urea derivatives having pharmacological activity and pharmaceutical compositions containing them | |
| PL321253A1 (en) | Novel aromatic compounds, method of obtaining them, their application as drugs and pharmaceutic agent containing them | |
| HUP0401567A3 (en) | Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them | |
| HUP0300057A3 (en) | Glucopyranosyloxy benzylbenzene derivatives, pharmaceutical compositions containing the same and intermediates for the preparation of the derivatives | |
| IL163831A0 (en) | Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing | |
| HUP0401898A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| EP1465656A4 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION | |
| HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
| HUP0201953A3 (en) | Benzene derivatives, preparation method and pharmaceutical compositions containing same | |
| PL338143A1 (en) | Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them | |
| HUP9800781A3 (en) | Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| AU2841199A (en) | Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine | |
| HUP0105443A3 (en) | Pharmaceutical compositions containing spisulosine compounds having antitumour activity | |
| HUP0104026A3 (en) | 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation | |
| HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
| PL352280A1 (en) | Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives | |
| HUP9800373A3 (en) | Steroide compounds of anticeptive and antiosteoporosive activity, process for producing them and pharmaceutical compositions containing the same | |
| HUP0103387A3 (en) | Quinazoline derivatives preparation thereof, medicament containing them and their intermediates | |
| HUP0202706A3 (en) | Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202725A3 (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity, process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |